Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4104824 Title: COMPOSITION À UTILISER DANS UNE MÉTHODE DE TRAITEMENT DE LA SURCHARGE PONDÉRALE ET DE L'OBÉSITÉ CHEZ DES PATIENTS PRÉSENTANT UN RISQUE CARDIOVASCULAIRE ÉLEVÉ

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
221703648
WO application number:
Type:
European patent granted for BE
Status:
Open
Publication number:
4104824
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
05/06/2013
Grant date:
21/05/2025
EP publication date:
21/12/2022
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
21/05/2025
EP B1 publication date:
21/05/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
05/06/2033

Applicant

Name:
Nalpropion Pharmaceuticals LLC
Legal Form:
From:
21/05/2025
Address:
155 Franklin Rd, Suite 450, Brentwood, TN 37027, United States (US)
To:

Inventor

1

Name:
KLASSEN, Preston
Legal Form:
Address:
La Jolla, 92037, United States (US)

2

Name:
TAYLOR, Kristin
Legal Form:
Address:
San Diego, 92127, United States (US)

Priority

Priority patent number:
201261656451 P
Priority date:
06/06/2012
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/137; A61K 31/485; A61P 3/04; A61P 9/00; A61P 9/04; A61P 9/10; A61K 9/20; G01G 19/414; G09B 5/06; G09B 19/00; G16H 20/10;

Publication

European Patent Bulletin

Issue number:
202521
Publication date:
21/05/2025
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
22/07/2025
Annual fee number:
13
Annual fee amount:
275 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type